Thatchaphon Chonwattanasakul - Healthlead Public CEO Director
| HL Stock | 7.00 0.50 6.67% |
Insider
Thatchaphon Chonwattanasakul is CEO Director of Healthlead Public
| Phone | 66 2 118 0884 |
| Web | https://www.healthleadgroup.com |
Healthlead Public Management Efficiency
The company has return on total asset (ROA) of 0.1033 % which means that it generated a profit of $0.1033 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1994 %, meaning that it generated $0.1994 on every $100 dollars invested by stockholders. Healthlead Public's management efficiency ratios could be used to measure how well Healthlead Public manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Nutchanat Montinard | Dohome Public | 34 | |
| Chatrchai Tuongratanaphan | Dohome Public | 62 | |
| Isara Rujikeatkamjorn | Siam Global House | 43 | |
| Somsak Tantitanawat | Humanica Public | N/A | |
| Adisak Sukumvitaya | Jay Mart Public | 67 | |
| Maruay Tangmitrphracha | Dohome Public | 31 | |
| Chalit Thongprayoon | Dohome Public | 62 | |
| Mayuree Seeta | Dohome Public | 37 | |
| Adisak Tangmitrphracha | Dohome Public | 69 | |
| Yuvadee PongAcha | Jay Mart Public | 67 | |
| Phannee Khetchompoo | Dohome Public | 34 | |
| Sutee Tanwanichkul | Humanica Public | N/A | |
| Panya Chutisiriwong | Jay Mart Public | N/A | |
| Khemchat Sungkakam | Siam Global House | 40 | |
| Kriangkai Suriyawanakul | Siam Global House | 34 | |
| Natcha Nititsopon | Jay Mart Public | N/A | |
| Pana Janviroj | Humanica Public | N/A | |
| Anavat Suriyawanakul | Siam Global House | ||
| Suvait Theeravachirakul | Dohome Public | 59 | |
| Bee Lim | Humanica Public | 51 | |
| Nataya Tangmitrphracha | Dohome Public | 64 | |
Management Performance
Healthlead Public Leadership Team
Elected by the shareholders, the Healthlead Public's board of directors comprises two types of representatives: Healthlead Public inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Healthlead. The board's role is to monitor Healthlead Public's management team and ensure that shareholders' interests are well served. Healthlead Public's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Healthlead Public's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sasithon Marukasonthi, Director Accounting | ||
| Thatchaphon Chonwattanasakul, CEO Director |
Healthlead Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Healthlead Public a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.2 | |||
| Return On Asset | 0.1 | |||
| Profit Margin | 0.07 % | |||
| Operating Margin | 0.09 % | |||
| Current Valuation | 6.02 B | |||
| Shares Outstanding | 272 M | |||
| Shares Owned By Insiders | 77.13 % | |||
| Shares Owned By Institutions | 0.73 % | |||
| Price To Book | 7.20 X | |||
| Price To Sales | 4.48 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Healthlead Stock
Healthlead Public financial ratios help investors to determine whether Healthlead Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Healthlead with respect to the benefits of owning Healthlead Public security.